Journal of Gastroenterology and Digestive Diseases

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Opinion Article - Journal of Gastroenterology and Digestive Diseases (2023) Volume 8, Issue 6

The role of gut-brain axis in gastrointestinal disorders: Implications for treatment.

Christos Alexander*

Department of Biosciences, Nottingham Trent University, Nottingham, UK

*Corresponding Author:
Christos Alexander
Department of Biosciences
Nottingham Trent University, Nottingham, UK
E-mail: christos.al@ntu.ac.uk

Received: 16-Oct-2023, Manuscript No. JGDD-23-120821; Editor assigned: 18-Oct-2023, Pre QC No. JGDD-23-120821 (PQ); Reviewed: 01-Nov-2023, QC No. JGDD-23-120821; Revised: 04-Nov-2023, Manuscript No. JGDD-23-120821 (R); Published: 10- Nov-2023, DOI: 10.35841/ jgdd -8.6.177

Citation: Alexander C. The role of gut-brain axis in gastrointestinal disorders: Implications for treatment. J Gastroenterol Dig Dis.2023;8(6):177

Visit for more related articles at Journal of Gastroenterology and Digestive Diseases

Introduction

This bidirectional communication system plays a crucial role in maintaining not only digestive health but also influencing overall well-being. In the context of gastrointestinal disorders, understanding the dynamics of the gut-brain axis has opened new avenues for treatment strategies that extend beyond traditional approaches. This article delves into the significance of the gut-brain axis in gastrointestinal disorders and explores its implications for innovative therapeutic interventions [1, 2].

The gut-brain axis is a complex network involving bidirectional communication between the central nervous system (CNS) and the enteric nervous system (ENS), which is often referred to as the "second brain" due to its extensive network of neurons within the gastrointestinal tract. This communication occurs through a variety of mechanisms, including the release of neurotransmitters, hormones, and immune system mediators. The gut-brain axis integrates signals from the gut microbiota, the enteric nervous system, and the endocrine system, influencing a range of physiological processes [3, 4].

The gut-brain axis plays a pivotal role in the development and progression of various gastrointestinal disorders. Stress, a significant factor in the modulation of the gut-brain axis, has been linked to conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and functional dyspepsia. Stress-induced alterations in gut motility, permeability, and immune responses can contribute to the onset and exacerbation of these disorders. Furthermore, the gut microbiota, a diverse community of microorganisms residing in the gastrointestinal tract, plays a crucial role in maintaining gut-brain communication. Dysbiosis, an imbalance in the composition of the gut microbiota, has been implicated in gastrointestinal disorders. Changes in the microbiota can affect the production of neurotransmitters and short-chain fatty acids, influencing both gut function and the central nervous system [5, 6].

The understanding of the gut-brain axis has profound implications for the treatment of gastrointestinal disorders. Targeting this communication system opens up novel therapeutic avenues that go beyond conventional approaches. Some promising strategies include: Probiotics, live microorganisms that confer health benefits when administered in adequate amounts, can modulate the gut microbiota and positively influence the gut-brain axis. Prebiotics, substances that promote the growth of beneficial microorganisms, can also be used to support a healthy gut microbiota [7, 8].

Cognitive-behavioral therapy (CBT) and mindfulness-based stress reduction (MBSR) have shown promise in managing gastrointestinal disorders by reducing stress and improving gut function. These interventions target the psychological component of the gut-brain axis. Certain dietary interventions, such as low-FODMAP diets or specific carbohydrate diets, can positively impact the gut microbiota and alleviate symptoms in individuals with IBS and IBD. Personalized nutrition approaches based on an individual's gut microbiota profile are emerging as potential treatments [9, 10].

Conclusion

The gut-brain axis represents a fascinating and multifaceted communication system that plays a crucial role in gastrointestinal health. The bidirectional interaction between the gut and the brain has far-reaching implications for the understanding and treatment of various gastrointestinal disorders. As research in this field continues to evolve, innovative therapeutic strategies targeting the gut-brain axis are likely to revolutionize the approach to managing and treating these conditions, providing new hope for individuals affected by gastrointestinal disorders.

References

  1. Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud. 2012;9(1):6.

    2. Indexed at, Google Scholar, Cross Ref

  2. Fallah Huseini H, Fakhrzadeh H, Larijani B, Shikh Samani AH. Review of anti-diabetic medicinal plant used in traditional medicine. J Med Plant Res. 2006;5(17):1-8.

    3. Google Scholar

  3. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clinical diabetes. 2008;26(2):77-82.

    4. Google Scholar

  4. American Diabetes Association. Economic costs of diabetes in the US in 2012. diabetes care 2013; 36: 1033–1046. Diabetes Care. 2013 ;36(6):1797.

    5. Indexed at, Google Scholar, Cross Ref

  5. Morphy R, Rankovic Z. Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005;48(21):6523-43.

    6. Indexed at, Google Scholar, Cross Ref

  6. Fukuda T, Bouchi R, Takeuchi T, Tsujimoto K, Minami I, Yoshimoto T et al. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study. Cardiovasc. Diabetol. 2018;17(1):1-2.

    7. Indexed at, Google Scholar, Cross Ref

  7. Marty E, Liu Y, Samuel A, Or O, Lane J. A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease. Bone. 2017;105:276-86.

    8. Google Scholar

  8. Tateya I, Fujiki N, Kurata K, Hasegawa S, Kojima H. Descending necrotizing mediastinitis following acute epiglottitis: a case report . Eur Arch Oto-Rhino-Laryngol. 2003;260:128-30.

    9. Indexed at, Google Scholar, Cross Ref

  9. Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud . 2012;9(1):6.

    10. Google Scholar

  10. Arumugam G, Manjula P, Paari N. A review: Anti diabetic medicinal plants used for diabetes mellitus. J Acute Dis. 2013;2(3):196-200.

    11. Google Scholar

Get the App